PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types

por Chia, Pei Ling, Ang, Koon Hwee, Thura, Min, Zeng, Qi
Publicado 2023

Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs

por Thura, Min, Sng, Joel Xuan En, Ang, Koon Hwee, Li, Jie, Gupta, Abhishek, Hong, Jimmy Ming, Hong, Cheng William, Zeng, Qi
Publicado 2021

PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse

por Thura, Min, Ye, Zu, Al-Aidaroos, Abdul Qader, Xiong, Qiancheng, Ong, Jun Yi, Gupta, Abhishek, Li, Jie, Guo, Ke, Ang, Koon Hwee, Zeng, Qi
Publicado 2021

Author Correction: PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse

por Thura, Min, Ye, Zu, Al-Aidaroos, Abdul Qader, Xiong, Qiancheng, Ong, Jun Yi, Gupta, Abhishek, Li, Jie, Guo, Ke, Ang, Koon Hwee, Zeng, Qi
Publicado 2021

The collagen-binding protein of Streptococcus mutans is involved in haemorrhagic stroke

por Nakano, Kazuhiko, Hokamura, Kazuya, Taniguchi, Naho, Wada, Koichiro, Kudo, Chiho, Nomura, Ryota, Kojima, Ayuchi, Naka, Shuhei, Muranaka, Yoshinori, Thura, Min, Nakajima, Atsushi, Masuda, Katsuhiko, Nakagawa, Ichiro, Speziale, Pietro, Shimada, Nobumitsu, Amano, Atsuo, Kamisaki, Yoshinori, Tanaka, Tokutaro, Umemura, Kazuo, Ooshima, Takashi
Publicado 2011

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies

por Chee, Cheng E., Ooi, Melissa, Lee, Soo-Chin, Sundar, Raghav, Heong, Valerie, Yong, Wei-Peng, Ng, Chin Hin, Wong, Andrea, Lim, Joline S. J., Tan, David S. P., Soo, Ross, Tan, Joshua T. C., Yang, Song, Thura, Min, Al-Aidaroos, Abdul Qader, Chng, Wee Joo, Zeng, Qi, Goh, Boon-Cher
Publicado 2023

Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody

por Loh, Amos Hong Pheng, Thura, Min, Gupta, Abhishek, Tan, Sheng Hui, Kuan, Kelvin Kam Yew, Ang, Koon Hwee, Merchant, Khurshid, Chang, Kenneth Tou En, Yon, Hui Yi, Chen, Yong, Cheng, Mathew Hern Wang, Mahadev, Arjandas, Ng, Matthew Chau Hsien, Seng, Michaela Su-Fern, Iyer, Prasad, Chia, Pei Ling, Soh, Shui Yen, Zeng, Qi
Publicado 2023

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein

por Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi
Publicado 2019

Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein

por Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi
Publicado 2021